TOYO GAAP EPS of $0.75 beats by $0.03, revenue of $142.8M misses by $60.1M

* TOYO press release [https://seekingalpha.com/pr/20518424-toyo-co-ltd-announces-unaudited-and-unreviewed-first-quarter-2026-financial-results-and] (TOYO [https://seekingalpha.com/symbol/TOYO]): Q1 GAAP EPS of $0.75 beats by $0.03.
* Revenue of $142.8M (+177% Y/Y) misses by $60.1M.
* Net income of $28.4 million, compared to a net loss of $3.7 million in Q1 2025
* EBITDA (Non-GAAP) of $48.1 million, compared to EBITDA of $2.4 million in Q1 2025
* Adjusted EBITDA (Non-GAAP) of $48.3 million, compared to adjusted EBITDA $2.8 million in Q1 2025
* Reaffirmed guidance.

MORE ON TOYO

* TOYO: Strong Execution Meets Rising Risk Layers (Rating Downgrade) [https://seekingalpha.com/article/4890597-toyo-strong-execution-meets-rising-risk-layers-rating-downgrade]
* TOYO Co., Ltd. (TOYO) Q4 2025 Earnings Call Transcript [https://seekingalpha.com/article/4887430-toyo-co-ltd-toyo-q4-2025-earnings-call-transcript]
* TOYO Non-GAAP EPS of $1.48, revenue of $427.4M beats by $28.5M [https://seekingalpha.com/news/4570559-toyo-non-gaap-eps-of-1_48-revenue-of-427_4m-beats-by-28_5m]
* Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag [https://seekingalpha.com/news/4569547-quant-snapshot-jjill-angiodynamics-lead-strong-buys-as-inmune-bio-terrestrial-energy-lag]
* Seeking Alpha’s Quant Rating on TOYO [https://seekingalpha.com/symbol/TOYO/ratings/quant-ratings]